# Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography

> **NCT03806725** · — · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Acute Kidney Injury
- Renal Insufficiency, Chronic
- Contrast-induced Nephropathy
- Liver Transplantation
- Contrast Media

## Interventions

- **DIAGNOSTIC_TEST:** Intravenous administration of iodinated contrast medium for coronary CT angiography

## Key facts

- **NCT ID:** NCT03806725
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-01
- **Primary completion:** 2021-11-22
- **Final completion:** 2022-03-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty with recruitment in this patient population.
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03806725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03806725, "Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03806725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*